| Huntington disease GP Bates, R Dorsey, JF Gusella, MR Hayden, C Kay, BR Leavitt, M Nance, ... Nature reviews Disease primers 1 (1), 1-21, 2015 | 2708 | 2015 |
| Huntington's disease: from molecular pathogenesis to clinical treatment CA Ross, SJ Tabrizi The Lancet Neurology 10 (1), 83-98, 2011 | 2125 | 2011 |
| Huntington's disease: a clinical review P McColgan, SJ Tabrizi European journal of neurology 25 (1), 24-34, 2018 | 1385 | 2018 |
| Huntington disease: natural history, biomarkers and prospects for therapeutics CA Ross, EH Aylward, EJ Wild, DR Langbehn, JD Long, JH Warner, ... Nature Reviews Neurology 10 (4), 204-216, 2014 | 1217 | 2014 |
| Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data SJ Tabrizi, DR Langbehn, BR Leavitt, RAC Roos, A Durr, D Craufurd, ... The Lancet Neurology 8 (9), 791-801, 2009 | 1162 | 2009 |
| Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data SJ Tabrizi, RI Scahill, G Owen, A Durr, BR Leavitt, RA Roos, B Borowsky, ... The Lancet Neurology 12 (7), 637-649, 2013 | 1078 | 2013 |
| PINK1-associated Parkinson's disease is caused by neuronal vulnerability to calcium-induced cell death S Gandhi, A Wood-Kaczmar, Z Yao, H Plun-Favreau, E Deas, K Klupsch, ... Molecular cell 33 (5), 627-638, 2009 | 829 | 2009 |
| Targeting huntingtin expression in patients with Huntington’s disease SJ Tabrizi, BR Leavitt, GB Landwehrmeyer, EJ Wild, C Saft, RA Barker, ... New England Journal of Medicine 380 (24), 2307-2316, 2019 | 815 | 2019 |
| Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis SJ Tabrizi, RI Scahill, A Durr, RAC Roos, BR Leavitt, R Jones, ... The Lancet Neurology 10 (1), 31-42, 2011 | 718 | 2011 |
| Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data SJ Tabrizi, R Reilmann, RAC Roos, A Durr, B Leavitt, G Owen, R Jones, ... The Lancet Neurology 11 (1), 42-53, 2012 | 646 | 2012 |
| Proteome-based plasma biomarkers for Alzheimer's disease A Hye, S Lynham, M Thambisetty, M Causevic, J Campbell, HL Byers, ... Brain 129 (11), 3042-3050, 2006 | 611 | 2006 |
| Biochemical abnormalities and excitotoxicity in Huntington's disease brain SJ Tabrizi, MWJ Cleeter, J Xuereb, JW Taanman, JM Cooper, ... Annals of Neurology: Official Journal of the American Neurological …, 1999 | 575 | 1999 |
| Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities SJ Tabrizi, MD Flower, CA Ross, EJ Wild Nature Reviews Neurology 16 (10), 529-546, 2020 | 550 | 2020 |
| Microglial activation in presymptomatic Huntington's disease gene carriers YF Tai, N Pavese, A Gerhard, SJ Tabrizi, RA Barker, DJ Brooks, P Piccini Brain 130 (7), 1759-1766, 2007 | 529 | 2007 |
| CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion JM Lee, EM Ramos, JH Lee, T Gillis, JS Mysore, MR Hayden, SC Warby, ... Neurology 78 (10), 690-695, 2012 | 490 | 2012 |
| Large C9orf72 hexanucleotide repeat expansions are seen in multiple neurodegenerative syndromes and are more frequent than expected in the UK population J Beck, M Poulter, D Hensman, JD Rohrer, CJ Mahoney, G Adamson, ... The American Journal of Human Genetics 92 (3), 345-353, 2013 | 466 | 2013 |
| The prevalence of Huntington's disease MD Rawlins, NS Wexler, AR Wexler, SJ Tabrizi, I Douglas, SJW Evans, ... Neuroepidemiology 46 (2), 144-153, 2016 | 462 | 2016 |
| Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis LM Byrne, FB Rodrigues, K Blennow, A Durr, BR Leavitt, RAC Roos, ... The Lancet Neurology 16 (8), 601-609, 2017 | 436 | 2017 |
| A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease M Björkqvist, EJ Wild, J Thiele, A Silvestroni, R Andre, N Lahiri, E Raibon, ... The Journal of experimental medicine 205 (8), 1869, 2008 | 425 | 2008 |
| Huntingtin lowering strategies for disease modification in Huntington’s disease SJ Tabrizi, R Ghosh, BR Leavitt Neuron 101 (5), 801-819, 2019 | 419 | 2019 |
